☆ 4.7 Meeting Abstract

First-In-Patient Proof of Safety and Efficacy of a 4th Generation Chimeric Antigen Receptor-Modified T Cells for the Treatment of Relapsed or Refractory CD30 Positive Lymphomas

MOLECULAR THERAPY (2015)

Get Full Text
Add to Collection

Journal

MOLECULAR THERAPY
Volume 23, Issue -, Pages S164-S164

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1016/S1525-0016(16)34024-2

Keywords

-

Categories

Biotechnology & Applied Microbiology Genetics & Heredity Medicine, Research & Experimental

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.